IndraLab

Statements


Mutated SCN5A activates LQT3. 7 / 7
| 7

reach
"For instance, SCN5A mutations can cause not only LQT3 and BrS, but also cardiac conduction disease, sick sinus syndrome, atrial fibrillation, or dilated cardiomyopathy."

reach
"The realization that SCN5A mutations producing LQT3 have a " gain-of-function " effect has lent support to our early suggestion to test sodium channel blockers, and especially mexiletine, as possible adjuvants in the management of LQT3 patients."

reach
"Interestingly, SCN5A mutations also cause LQT3, and some specific " overlap " mutations have been implicated in both BrS and LQT3."

reach
"The LQT3 form of this disease is caused by mutations of the SCN5A sodium-channel gene."

reach
"The LQT3 phenotype is only caused by mutations of the SCN5A (LQT3) gene (so far)."

reach
"Compound SCN5A mutations causing LQT3 are uncommon, and in some instances one mutation rescues the Na + channel abnormalities of the other [XREF_BIBR - XREF_BIBR]."

reach
"SCN5A mutations producing LQT3 generally exhibit a disruption in channel inactivation leading to an increase in persistent current, which has pathophysiological relevance during the plateau phase of the action potential."